Conference abstract · 14 Jun 2018
Conference abstractPublished 14 Dec 2018
Site attachment inhibition therapeutics: Progress update
Alumnus Melbourne University, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The current researcher has in previous conferences and publications detailed the conceptualization and development of the new, or third, branch of antimicrobial therapeutics, namely site attachment inhibition which involves negation of cellular attachment by infective agents. This based on the issues with metaphorical superbugs, development of antimicrobial resistance, and the general lack of success currently with respect to the previous two branches which focused on (1) replication of infective agent and, (2) immune system enhancement. This talk explains that site attachment inhibition is intended to consist of both treatment of established infection but also new generation immunization programs. The likely success of new generation immunization programs, based on prenatal stem cell therapy is intended to involve gene mutagenesis or knockout. This preventative (or, immunization) therapy intended to be spanning right back to spermatogenesis and oogenesis. The validation for likely success includes the innate resistance or immunity achieved by inherited genetic mutations, including CCR5-Δ32 against HIV. One major issue is a differentiation between association and causation. Even the known CCR5-Δ32 mutation has not been completely confirmed as direct/causative of the inhibition of attachment observed in research analyses. New content presented in this talk will involve methods around the above issues to do with association and causation. These methods include the use of CRISPR technology in order to analyze properly the genes (and, methods) utilized by those with innate resistance (immunity) in order to determine the proper prenatal genetic therapy, as mentioned above, in new generation immunization programs. Prenatal genetic therapy is becoming increasingly discussed and utilized in medicine and surgery. However, an important issue remains the ethics committee and community consideration in such treatment strategy consideration.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · Dec 2017
Antimicrobes 2017: Site attachment inhibition therapeutics - Simon Raymond - Melbourne University
Short communication · 2017
Site Attachment Inhibition Therapeutics: A Core Summary
Conference abstract · 6 Aug 2018
Site attachment inhibition therapeutics progress update: A Dealing with association and causation issues
Conference abstract · 29 Oct 2020
Site Attachment Inhibition Update: Application in Veterinary Science.
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 14 Apr 2026
Ethiopian Child Immunization Coverage Prevalence and Determinants: Evidence from the 2019 Mini-Demographic and Health Survey
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Simon Raymond”
